1. Home
  2. LMND vs CRNX Comparison

LMND vs CRNX Comparison

Compare LMND & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lemonade Inc.

LMND

Lemonade Inc.

HOLD

Current Price

$62.45

Market Cap

4.0B

Sector

Finance

ML Signal

HOLD

Logo Crinetics Pharmaceuticals Inc.

CRNX

Crinetics Pharmaceuticals Inc.

HOLD

Current Price

$36.54

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LMND
CRNX
Founded
2015
2008
Country
United States
United States
Employees
1282
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
3.9B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
LMND
CRNX
Price
$62.45
$36.54
Analyst Decision
Hold
Strong Buy
Analyst Count
8
9
Target Price
$64.75
$74.78
AVG Volume (30 Days)
1.9M
1.1M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,039,000.00
Revenue This Year
$64.93
$722.66
Revenue Next Year
$32.87
$183.79
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$24.31
$24.10
52 Week High
$99.90
$57.99

Technical Indicators

Market Signals
Indicator
LMND
CRNX
Relative Strength Index (RSI) 50.49 43.63
Support Level $49.09 $33.23
Resistance Level $69.30 $37.23
Average True Range (ATR) 3.55 1.69
MACD 0.57 0.28
Stochastic Oscillator 60.74 64.01

Price Performance

Historical Comparison
LMND
CRNX

About LMND Lemonade Inc.

Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes. The company is using technology, data, artificial intelligence, contemporary design, and social impact to deliver delightful and affordable insurances. The Company operates in one report segment providing personal property and casualty insurance products within the United States and Europe, including the UK.

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its main product, Palsonify (paltusotine), is a once-daily, oral treatment approved by the FDA for adults with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option. Additionally, the company's development pipeline includes several programs, including a late-stage investigational candidate, atumelnant, currently in development for CAH and ADCS, and CRN09682, a NDC candidate that is being developed to treat SST2-expressing NETs and other SST2-expressing solid tumors.

Share on Social Networks: